Aurobindo Pharma consolidated net profit rises 90.59% in the December 2023 quarter

Sales rise 13.83% to Rs 7271.23 crore

Net profit of Aurobindo Pharma rose 90.59% to Rs 936.29 crore in the quarter ended December 2023 as against Rs 491.26 crore during the previous quarter ended December 2022. Sales rose 13.83% to Rs 7271.23 crore in the quarter ended December 2023 as against Rs 6387.97 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales7271.236387.97 14 OPM %21.9914.93 -PBDT1685.691001.51 68 PBT1262.42680.11 86 NP936.29491.26 91

Powered by Capital Market - Live News